tiprankstipranks
Trending News
More News >
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
US Market

Drugs Made In America Acquisition Corp. (DMAA) Income Statement

Compare
2 Followers

Drugs Made In America Acquisition Corp. Income Statement

Last quarter (Q3 2025), Drugs Made In America Acquisition Corp.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Drugs Made In America Acquisition Corp.'s net income was $2.18M. See Drugs Made In America Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24
Total Revenue
$ 0.00
Gross Profit
$ 0.00
Operating Expenses
-
Depreciation and Amortization
-
EBITDA
$ 0.00
Operating Income
$ -479.00
Other Income/Expenses
$ 0.00
Pretax Income
$ -479.00
Net Income
$ -479.00
Per Share Metrics
Basic EPS
$ -0.06
Diluted EPS
$ -0.06
Weighted Average Shares Outstanding
8.57M
Weighted Average Shares Outstanding (Diluted)
8.57M
Currency in USD

Drugs Made In America Acquisition Corp. Earnings and Revenue History